Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Product/R&D News
1/22/2025
YolTech to Initiate a Clinical Trial of FIC Bone Marrow-Targeted In V...
1/21/2025
NiKang Does First Patient in a Phase 1b/2 Study of NKT2152 in Combo fo...
1/21/2025
CARsgen's Allogeneic CD38 CAR-T Therapy Administers First Dose in Inve...
1/21/2025
Zai Lab's NDA for Schizophrenia Treatment KarXT Accepted in China
1/21/2025
NMPA Approves Two Homegrown Oncology Therapies for Lung and Ovarian Ca...
1/20/2025
NMPA Expands Label for Genrix Bio's Xeligekimab in Radiographic AS
1/20/2025
NMPA Expands Label for Kelun-Biotech's Tagitanlimab in First-Line NPC ...
1/17/2025
Daiichi Sankyo Submits NDA for Pexidartinib (PLX3397) in China as the ...
1/16/2025
Alphamab Advances Oncology Pipeline with Phase 2 Trial of TROP-2/HER3 ...
1/15/2025
Luye Pharma Advances CNS Pipeline with Phase II Trial for LY03015 in C...
1/15/2025
Ucello Wins FDA IND Approval for Pioneering Allogeneic CAR-T Therapy
1/14/2025
ImmuneOnco Begins Trial of Instil's NSCLC Drug in China
1/13/2025
CirCode Receives NMPA IND Approval for HM2002 Injection
1/13/2025
Akeso Launches Phase 3 Trial for Ivonescimab (AK112)
1/13/2025
Regor Releases Phase 2a Topline Results for GLP-1 RGT-075
1/13/2025
J&J's Balversa (Erdafitinib) Gains NMPA Approval for Advanced Urotheli...
1/13/2025
Hengruiand Kailera Report Positive Data from Phase 2 Obesity Trial of ...
1/12/2025
WuXi Biologics Announces Agreement with Candid Therapeutics on Trispec...
1/11/2025
Sanofi's Sarclisa (Isatuximab) Approved in China, Pioneering Use of Re...
1/11/2025
China Approves Combination Therapy of Padcev and Keytruda
1/11/2025
Merck's Gardasil 4 Receives New Indication Approval for Males in China
1/11/2025
U.S. FDA Granted Priority Review to Dizal's Sunvozertinib NDA
1/6/2025
GSK's Nucala Gains Expanded Approval in China for CRSwNP Treatment
1/6/2025
Chinese Researchers Use AI to Accelerates Discovery of Potential Glauc...
1/3/2025
Platinum Life Receives Conditional Approval for China's First Stem Cel...
1/3/2025
Gilead's Sunlenca (lenacapavir) Receives Marketing Approval in China
1/3/2025
Astellas' Vyloy (zolbetuximab) Receives Marketing Approval in China fo...
1/3/2025
Biocon Wins NMPA Approval for Tacrolimus Capsules in China
12/30/2024
TJ Bio Submits BLA for Genexine's Long-Acting Pediatric Growth Hormone...
12/30/2024
NMPA Approves Alpha/AZ's Zorifer for NSCLC
Page:
5
/
11
Total number of articles:
316
:
[First]
[<<]
[3]
[4]
[5]
[6]
[7]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit